{"anonymous": [], "male": ["Carlos", "Fabio"], "word_count": "772", "persons": ["Oyarzun, Carlos (1981- )", "Taborre, Fabio (1985- )"], "female": [], "pub_date": "2015-07-30T00:00:00Z", "subject": ["Bicycles and Bicycling", "Doping (Sports)", "Tests (Drug Use)"], "organizations": ["AstraZeneca PLC", "FibroGen Inc."], "news_desk": "Sports", "lead_paragraph": "FG-4592, which increases production of red blood cells, is not approved for human consumption but nonetheless has led to two positive tests just this month.", "headline": {"main": "A Drug Hits Cycling Before It Hits the Market", "print_headline": "Drug Hits Cycling Before It Hits Market"}, "snippet": "FG-4592, which increases production of red blood cells, is not approved for human consumption but nonetheless has led to two positive tests just this month.", "subsection_name": "Cycling", "_id": "55b958c6798810561813c24e"}